GE Healthcare Ireland Limited GE Healthcare Omnipaque Injection, 300 mg/mL recall: Presence of particulate matter
Presence of particulate matter
The hazard: Sterility or particulate concern
Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.
What the notice says: Presence of particulate matter
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0447-2026
- Published
- April 15, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- GE Healthcare Ireland Limited
- Product type
- Prescription & OTC drugs
- Units affected
- 866,570 vials
- Distribution
- Nationwide
- Made in
- Ireland
- Lot / code info
- Lot# 17225029; Exp. September 3, 2028 Lot# 17265376; Exp. October 3, 2028 Lot# 17270885; Exp. September 10, 2028 Lot# 17292246; Exp. October 4, 2028 Lot# 17301805; Exp. October 18, 2028 Lot# 17301807; Exp. September 7, 2028 Lot# 17301810; Exp. October 20, 2028 Lot# 17304992; Exp. October 5, 2028 Lot# 17304993; Exp. October 19, 2028 Lot# 17304996; Exp. November 25, 2028 Lot# 17321225; Exp. September 8, 2028 Lot# 17333589; Exp. November 24, 2028 Lot# 17333611; Exp. November 26. 2028 Lot# 17333613; Exp. November 23. 2028 Lot# 17357000; Exp. December 5, 2028 Lot# 17366399; Exp. December 14, 2028 Lot# 17376486; Exp. December 14, 2028 Lot# 17404114; Exp. December 6, 2028
Products covered by this recall
GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.
Check your product
The notice names 40 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 17225029
- 17265376
- 17270885
- 17292246
- 17301805
- 17301807
- 17301810
- 17304992
- 17304993
- 17304996
- 17321225
- 17333589
- 17333611
- 17333613
- 17357000
- 17366399
- 17376486
- 17404114
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- September 3
- 2028 Lot# 17265376
- October 3
- 2028 Lot# 17270885
- September 10
- 2028 Lot# 17292246
- October 4
- 2028 Lot# 17301805
- October 18
- 2028 Lot# 17301807
- September 7
- 2028 Lot# 17301810
- October 20
- 2028 Lot# 17304992
- October 5
- 2028 Lot# 17304993
- October 19
- 2028 Lot# 17304996
- November 25
- 2028 Lot# 17321225
NDC number
On the carton and again on the bottle or blister label.
- 0407-1413-63
Package size
Match the net weight or the piece count on the front of the pack.
- 300 mg
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
GE Healthcare Ireland Limited — Particulate matter or a sterility failure prompted this notice, the most common reason injectable and ophthalmic products are withdrawn.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- Do not use a vial or syringe with visible particles, cloudiness or discolouration, whether or not it is on the recall list.
- Call your prescriber or pharmacy today about a replacement from an unaffected lot — do not simply skip doses of a medicine you depend on.
- If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: GE Healthcare Ireland Limited — Ida Business Park, Carrigtwohill
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was GE Healthcare Ireland Limited prescription & otc drugs recalled?
Presence of particulate matter Presence of particulate matter
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 17225029, 17265376, 17270885; best-by date September 3 or 2028 Lot# 17265376. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 6 months ago
GE Healthcare Ireland Limited GE Healthcare Omnipaque Injection, 350 mg/mL recall: Presence of particulate matter
Presence of particulate matter
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 11 days ago
Carolina Infusion, LLC Quad-Mix Injectable, Packaged in single-use dosage syringes recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tirzepatide/Cyanocobalamin 26/2 MG/ML Injectable recall: Lack of Assurance of Sterility: Related to formulation using bacteriostic
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tri-MIX ,30/1/20, injectable recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tri-MIX ,30/1/10, injectable recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.